van der Kwast TH - Search Results

1

Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sections.

Vis AN, Kranse R, Nigg AL, van der Kwast TH. Vis AN, et al. Among authors: van der kwast th. Am J Clin Pathol. 2000 Mar;113(3):369-73. doi: 10.1309/CQWY-E3F6-9KDN-YV36. Am J Clin Pathol. 2000. PMID: 10705817

2

Quantitative immunohistochemistry of androgen receptors in a microsphere model system and in prostate tissue sections.

Houtsmuller AB, Janssen PJ, Nigg AL, Hoedemaeker RF, van der Kwast TH. Houtsmuller AB, et al. Among authors: van der kwast th. Anal Quant Cytol Histol. 1998 Oct;20(5):365-72. Anal Quant Cytol Histol. 1998. PMID: 9801754

3

Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.

Vis AN, Noordzij MA, Fitoz K, Wildhagen MF, Schröder FH, van der Kwast TH. Vis AN, et al. Among authors: van der kwast th. J Urol. 2000 Dec;164(6):2156-61. J Urol. 2000. PMID: 11061947

4

Staging prostate cancer.

Hoedemaeker RF, Vis AN, Van Der Kwast TH. Hoedemaeker RF, et al. Among authors: van der kwast th. Microsc Res Tech. 2000 Dec 1;51(5):423-9. doi: 10.1002/1097-0029(20001201)51:5<423::AID-JEMT4>3.0.CO;2-4. Microsc Res Tech. 2000. PMID: 11074612 Review.

5

Should we replace the Gleason score with the amount of high-grade prostate cancer?

Vis AN, Roemeling S, Kranse R, Schröder FH, van der Kwast TH. Vis AN, et al. Among authors: van der kwast th. Eur Urol. 2007 Apr;51(4):931-9. doi: 10.1016/j.eururo.2006.07.051. Epub 2006 Aug 15. Eur Urol. 2007. PMID: 16935413

6

Metastatic disease of screen-detected prostate cancer : characteristics at diagnosis.

Roemeling S, Kranse R, Vis AN, Gosselaar C, van der Kwast TH, Schröder FH. Roemeling S, et al. Among authors: van der kwast th. Cancer. 2006 Dec 15;107(12):2779-85. doi: 10.1002/cncr.22374. Cancer. 2006. PMID: 17109445 Free article.

7

Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.

Schröder FH, Roobol-Bouts M, Vis AN, van der Kwast T, Kranse R. Schröder FH, et al. Urology. 2001 Jan;57(1):83-90. doi: 10.1016/s0090-4295(00)00863-3. Urology. 2001. PMID: 11164149 Clinical Trial.

8

Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions.

Hoedemaeker RF, Kranse R, Rietbergen JB, Kruger AE, Schröder FH, van der Kwast TH. Hoedemaeker RF, et al. Among authors: van der kwast th. Cancer. 1999 Jan 1;85(1):145-52. Cancer. 1999. PMID: 9921986 Clinical Trial.

9

Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy.

Vis AN, Boerma MO, Ciatto S, Hoedemaeker RF, Schröder FH, van der Kwast TH. Vis AN, et al. Among authors: van der kwast th. Urology. 2000 Oct 1;56(4):617-21. doi: 10.1016/s0090-4295(00)00681-6. Urology. 2000. PMID: 11018617

10

Defining the window of opportunity in screening for prostate cancer: validation of a predictive tumor classification model.

Vis AN, Hoedemaeker RF, van der Kwast TH, Schröder FH. Vis AN, et al. Among authors: van der kwast th. Prostate. 2001 Feb 1;46(2):154-62. doi: 10.1002/1097-0045(20010201)46:2<154::aid-pros1019>3.0.co;2-1. Prostate. 2001. PMID: 11170143 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

483 results

Search Page

Filters